CLEARVISE AG (ABO.DE) Fundamental Analysis & Valuation

FRA:ABO • DE000A1EWXA4

Current stock price

1.22 EUR
-0.02 (-1.61%)
Last:

This ABO.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ABO.DE Profitability Analysis

1.1 Basic Checks

  • ABO had negative earnings in the past year.
  • ABO had a positive operating cash flow in the past year.
  • Of the past 5 years ABO 4 years were profitable.
  • Each year in the past 5 years ABO had a positive operating cash flow.
ABO.DE Yearly Net Income VS EBIT VS OCF VS FCFABO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • With a Return On Assets value of -0.17%, ABO is not doing good in the industry: 68.18% of the companies in the same industry are doing better.
  • With a Return On Equity value of -0.44%, ABO is not doing good in the industry: 68.18% of the companies in the same industry are doing better.
  • ABO has a worse Return On Invested Capital (0.99%) than 63.64% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ABO is below the industry average of 5.34%.
Industry RankSector Rank
ROA -0.17%
ROE -0.44%
ROIC 0.99%
ROA(3y)2.27%
ROA(5y)1.33%
ROE(3y)6.14%
ROE(5y)3.7%
ROIC(3y)2.96%
ROIC(5y)2.52%
ABO.DE Yearly ROA, ROE, ROICABO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • With a decent Operating Margin value of 18.27%, ABO is doing good in the industry, outperforming 72.73% of the companies in the same industry.
  • ABO's Operating Margin has declined in the last couple of years.
  • ABO has a better Gross Margin (96.58%) than 95.45% of its industry peers.
  • In the last couple of years the Gross Margin of ABO has remained more or less at the same level.
Industry RankSector Rank
OM 18.27%
PM (TTM) N/A
GM 96.58%
OM growth 3Y25.68%
OM growth 5Y-3.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y-0.49%
ABO.DE Yearly Profit, Operating, Gross MarginsABO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ABO.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ABO is destroying value.
  • ABO has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ABO has been increased compared to 5 years ago.
  • ABO has a worse debt/assets ratio than last year.
ABO.DE Yearly Shares OutstandingABO.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ABO.DE Yearly Total Debt VS Total AssetsABO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • ABO has an Altman-Z score of 0.53. This is a bad value and indicates that ABO is not financially healthy and even has some risk of bankruptcy.
  • ABO's Altman-Z score of 0.53 is on the low side compared to the rest of the industry. ABO is outperformed by 63.64% of its industry peers.
  • ABO has a debt to FCF ratio of 22.35. This is a negative value and a sign of low solvency as ABO would need 22.35 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 22.35, ABO is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
  • ABO has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.35, ABO perfoms like the industry average, outperforming 40.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 22.35
Altman-Z 0.53
ROIC/WACC0.29
WACC3.43%
ABO.DE Yearly LT Debt VS Equity VS FCFABO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • ABO has a Current Ratio of 1.61. This is a normal value and indicates that ABO is financially healthy and should not expect problems in meeting its short term obligations.
  • ABO has a Current ratio of 1.61. This is comparable to the rest of the industry: ABO outperforms 50.00% of its industry peers.
  • ABO has a Quick Ratio of 1.61. This is a normal value and indicates that ABO is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.61, ABO is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.61
ABO.DE Yearly Current Assets VS Current LiabilitesABO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ABO.DE Growth Analysis

3.1 Past

  • ABO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -89.42%.
  • Looking at the last year, ABO shows a very negative growth in Revenue. The Revenue has decreased by -19.53% in the last year.
  • The Revenue has been growing slightly by 1.75% on average over the past years.
EPS 1Y (TTM)-89.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-19.53%
Revenue growth 3Y3.15%
Revenue growth 5Y1.75%
Sales Q2Q%3.62%

3.2 Future

  • Based on estimates for the next years, ABO will show a very strong growth in Earnings Per Share. The EPS will grow by 64.65% on average per year.
  • ABO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.97% yearly.
EPS Next Y87.82%
EPS Next 2Y115%
EPS Next 3Y64.65%
EPS Next 5YN/A
Revenue Next Year10.19%
Revenue Next 2Y13.51%
Revenue Next 3Y7.97%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ABO.DE Yearly Revenue VS EstimatesABO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ABO.DE Yearly EPS VS EstimatesABO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 0.15

More info and screens

Find the best growth stocksShow best growing peers

5

4. ABO.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ABO. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 16.85, which indicates a correct valuation of ABO.
  • 72.73% of the companies in the same industry are more expensive than ABO, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 22.62. ABO is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 16.85
ABO.DE Price Earnings VS Forward Price EarningsABO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as ABO.
  • Based on the Price/Free Cash Flow ratio, ABO is valued cheaper than 86.36% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.69
EV/EBITDA 13.56
ABO.DE Per share dataABO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • ABO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ABO's earnings are expected to grow with 64.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y115%
EPS Next 3Y64.65%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. ABO.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.84%, ABO is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.28, ABO pays a better dividend. On top of this ABO pays more dividend than 90.91% of the companies listed in the same industry.
  • ABO's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 4.84%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ABO.DE Yearly Dividends per shareABO.DE Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

DP0%
EPS Next 2Y115%
EPS Next 3Y64.65%
ABO.DE Yearly Income VS Free CF VS DividendABO.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

More info and screens

Find the best dividend stocksShow peers with best dividend

ABO.DE Fundamentals: All Metrics, Ratios and Statistics

CLEARVISE AG

FRA:ABO (4/22/2026, 7:00:00 PM)

1.22

-0.02 (-1.61%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)11-14
Earnings (Next)04-30
Inst Owners6.34%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap91.94M
Revenue(TTM)35.41M
Net Income(TTM)-707.70K
Analysts85.71
Price Target2.82 (131.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.84%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.85
P/S 2.6
P/FCF 8.69
P/OCF 8.69
P/B 0.57
P/tB 0.57
EV/EBITDA 13.56
EPS(TTM)-0.01
EYN/A
EPS(NY)0.07
Fwd EY5.93%
FCF(TTM)0.14
FCFY11.5%
OCF(TTM)0.14
OCFY11.5%
SpS0.47
BVpS2.13
TBVpS2.13
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -0.17%
ROE -0.44%
ROCE 1.64%
ROIC 0.99%
ROICexc 1.05%
ROICexgc 1.05%
OM 18.27%
PM (TTM) N/A
GM 96.58%
FCFM 29.86%
ROA(3y)2.27%
ROA(5y)1.33%
ROE(3y)6.14%
ROE(5y)3.7%
ROIC(3y)2.96%
ROIC(5y)2.52%
ROICexc(3y)3.53%
ROICexc(5y)2.94%
ROICexgc(3y)3.56%
ROICexgc(5y)2.99%
ROCE(3y)4.91%
ROCE(5y)4.17%
ROICexgc growth 3Y9.45%
ROICexgc growth 5Y-12.72%
ROICexc growth 3Y10.45%
ROICexc growth 5Y-12.08%
OM growth 3Y25.68%
OM growth 5Y-3.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y-0.49%
F-Score4
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 22.35
Debt/EBITDA 9.67
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 47.02%
Profit Quality N/A
Current Ratio 1.61
Quick Ratio 1.61
Altman-Z 0.53
F-Score4
WACC3.43%
ROIC/WACC0.29
Cap/Depr(3y)124.13%
Cap/Depr(5y)91.46%
Cap/Sales(3y)46.11%
Cap/Sales(5y)37.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y87.82%
EPS Next 2Y115%
EPS Next 3Y64.65%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.53%
Revenue growth 3Y3.15%
Revenue growth 5Y1.75%
Sales Q2Q%3.62%
Revenue Next Year10.19%
Revenue Next 2Y13.51%
Revenue Next 3Y7.97%
Revenue Next 5YN/A
EBIT growth 1Y-60.34%
EBIT growth 3Y29.64%
EBIT growth 5Y-1.33%
EBIT Next Year435.45%
EBIT Next 3Y84.85%
EBIT Next 5YN/A
FCF growth 1Y-70.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-74.97%
OCF growth 3Y-7.16%
OCF growth 5Y-8.38%

CLEARVISE AG / ABO.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CLEARVISE AG?

ChartMill assigns a fundamental rating of 4 / 10 to ABO.DE.


Can you provide the valuation status for CLEARVISE AG?

ChartMill assigns a valuation rating of 5 / 10 to CLEARVISE AG (ABO.DE). This can be considered as Fairly Valued.


How profitable is CLEARVISE AG (ABO.DE) stock?

CLEARVISE AG (ABO.DE) has a profitability rating of 3 / 10.


How financially healthy is CLEARVISE AG?

The financial health rating of CLEARVISE AG (ABO.DE) is 3 / 10.